Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Adverse effects of vaccines [[electronic resource] ] : evidence and causality / / Institute of Medicine of the National Academies
| Adverse effects of vaccines [[electronic resource] ] : evidence and causality / / Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2012 |
| Descrizione fisica | 1 online resource (895 p.) |
| Disciplina | 615.3/72 |
| Altri autori (Persone) | StrattonKathleen R |
| Soggetto topico |
Vaccination - Complications
Bacterial diseases - Prevention Virus diseases - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-38012-8
9786613558039 0-309-21436-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Approach -- Evaluating biological mechanisms of adverse events -- Measles, mumps, and rubella vaccine -- Varicella virus vaccine -- Influenza vaccine -- Hepatitis A vaccine -- Hepatitis B vaccine -- Human papillomavirus vaccine -- Diphtheria toxoid-, tetanus toxoid-, and acellular pertussis-containing vaccines -- Meningococcal vaccine -- Injection-related adverse events -- Concluding comments. |
| Record Nr. | UNINA-9910451981803321 |
| Washington, D.C., : National Academies Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse effects of vaccines [[electronic resource] ] : evidence and causality / / Institute of Medicine of the National Academies
| Adverse effects of vaccines [[electronic resource] ] : evidence and causality / / Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2012 |
| Descrizione fisica | 1 online resource (895 p.) |
| Disciplina | 615.3/72 |
| Altri autori (Persone) | StrattonKathleen R |
| Soggetto topico |
Vaccination - Complications
Bacterial diseases - Prevention Virus diseases - Prevention |
| ISBN |
1-280-38012-8
9786613558039 0-309-21436-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Approach -- Evaluating biological mechanisms of adverse events -- Measles, mumps, and rubella vaccine -- Varicella virus vaccine -- Influenza vaccine -- Hepatitis A vaccine -- Hepatitis B vaccine -- Human papillomavirus vaccine -- Diphtheria toxoid-, tetanus toxoid-, and acellular pertussis-containing vaccines -- Meningococcal vaccine -- Injection-related adverse events -- Concluding comments. |
| Record Nr. | UNINA-9910779294303321 |
| Washington, D.C., : National Academies Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse effects of vaccines : evidence and causality / / Institute of Medicine of the National Academies
| Adverse effects of vaccines : evidence and causality / / Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2012 |
| Descrizione fisica | 1 online resource (895 p.) |
| Disciplina | 615.3/72 |
| Altri autori (Persone) | StrattonKathleen R |
| Soggetto topico |
Vaccination - Complications
Bacterial diseases - Prevention Virus diseases - Prevention |
| ISBN |
1-280-38012-8
9786613558039 0-309-21436-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Approach -- Evaluating biological mechanisms of adverse events -- Measles, mumps, and rubella vaccine -- Varicella virus vaccine -- Influenza vaccine -- Hepatitis A vaccine -- Hepatitis B vaccine -- Human papillomavirus vaccine -- Diphtheria toxoid-, tetanus toxoid-, and acellular pertussis-containing vaccines -- Meningococcal vaccine -- Injection-related adverse events -- Concluding comments. |
| Record Nr. | UNINA-9910815408503321 |
| Washington, D.C., : National Academies Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bacterial infections of humans : epidemiology and control / edited by Alfred S. Evans and Philip S. Brachman
| Bacterial infections of humans : epidemiology and control / edited by Alfred S. Evans and Philip S. Brachman |
| Autore | Evans, Alfred S. |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | New York : Plenum Medical Book Co., c1998 |
| Descrizione fisica | xxix, 888 p. : ill., maps ; 29 cm |
| Disciplina | 614.57 |
| Altri autori (Persone) | Brachman, Philip S. |
| Soggetto topico |
Bacterial diseases - Epidemiology
Bacterial diseases - Prevention Bacterial Infections - Epidemiology Bacterial Infections - Prevention & control |
| ISBN | 0306453231 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISALENTO-991003426339707536 |
Evans, Alfred S.
|
||
| New York : Plenum Medical Book Co., c1998 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. del Salento | ||
| ||
Fighting superbugs [[electronic resource] ] : DOD's response to multidrug-resistant infections in military treatment facilities : hearing before the Subcommittee on Oversight and Investigations of the Committee on Armed Services, House of Representatives, One Hundred Eleventh Congress, second session, hearing held September 29, 2010
| Fighting superbugs [[electronic resource] ] : DOD's response to multidrug-resistant infections in military treatment facilities : hearing before the Subcommittee on Oversight and Investigations of the Committee on Armed Services, House of Representatives, One Hundred Eleventh Congress, second session, hearing held September 29, 2010 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2010 |
| Descrizione fisica | 1 online resource (iii, 85 pages) |
| Soggetto topico |
Multidrug resistance
Drug resistance in microorganisms Bacterial diseases - Treatment Bacterial diseases - Prevention Nosocomial infections - Prevention Military hospitals, American |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Fighting superbugs |
| Record Nr. | UNINA-9910703168403321 |
| Washington : , : U.S. G.P.O., , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New strategies combating bacterial infection / / edited by Iqbal Ahmad and Farrukh Aqil
| New strategies combating bacterial infection / / edited by Iqbal Ahmad and Farrukh Aqil |
| Pubbl/distr/stampa | Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2009 |
| Descrizione fisica | 1 online resource (324 p.) |
| Disciplina |
362.196/92
616.92 |
| Soggetto topico |
Bacterial diseases - Prevention
Bacterial diseases - Treatment |
| ISBN |
1-282-02638-0
9786612026386 3-527-62293-4 3-527-62294-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
New Strategies Combating Bacterial Infection; Contents; Preface; List of Contributors; 1 Molecular Mechanisms of Antibiotic Resistance: The Need for Novel Antimicrobial Therapies; 1.1 Introduction; 1.2 Molecular Mechanisms of Resistance; 1.3 β-Lactams; 1.4 Glycopeptides; 1.5 Lantibiotics; 1.6 Aminoglycosides; 1.7 Macrolides; 1.8 Tetracyclines; 1.9 Fluoroquinolones; 1.10 Conclusions; References; 2 Novel Approaches to Combat Drug-Resistant Bacteria; 2.1 Introduction; 2.2 Approaches to Antibacterial Drug Discovery and Combating the Problem of Drug Resistance
2.2.1 Search for New Antibiotics from Microbial Sources2.2.1.1 Conventional Culturing Methods; 2.2.1.2 Novel Culturing Environments; 2.2.1.3 Heterologous DNA-Based Approaches; 2.2.1.4 Metagenomics and Molecular Engineering; 2.2.2 Role of Genomics in New Antibacterial Drug Discovery; 2.2.3 Antimicrobial Peptides as New Anti-Infective Drugs; 2.3 Combination Drug Therapy; 2.4 Strategies to Target Mechanisms of Drug Resistance; 2.4.1 Bacterial Efflux Systems and Efflux Pump Inhibition; 2.5 Quorum Sensing Inhibition: A Novel Anti-Infective Drug Target; 2.5.1 Anti-QS Compound Effects In Vitro 2.5.2 Efficacy of QS-Inhibitory Compounds in Animal Infection Models2.6 Phage Therapy: An Alternative Therapy; 2.7 Antibiotic Use Policy: Practical Management of the Problem of Antibiotic Resistance; 2.8 Conclusions; References; 3 Promising Current Drug Candidates in Clinical Trials and Natural Products Against Multidrug-Resistant Tuberculosis; 3.1 Introduction; 3.2 Current MDR-TB Treatment; 3.3 Current Drugs in Development Against MDR-TB; 3.3.1 Fluoroquinolones (Gatifloxacin and Moxifloxacin); 3.3.1.1 Fluoroquinolones against MDR-TB; 3.3.1.2 Gatifloxacin; 3.3.1.3 Moxifloxacin; 3.3.2 PA-824 3.3.3 Diarylquinoline TMC2073.3.4 Nitroimidazo-Oxazole OPC-67683; 3.3.5 SQ-109; 3.3.6 Pyrrole LL-3858; 3.4 Natural Products Against MDR-TB; 3.4.1 Fungi; 3.4.1.1 Thiolactomycin; 3.4.1.2 Pacidamycin Family; 3.4.1.3 Capuramycin; 3.4.1.4 Caprazamycin; 3.4.2 Plants; 3.4.2.1 Calanolide; 3.4.2.2 Diospyrin; 3.4.3 Marine Natural Products; 3.4.3.1 Aerothionin; 3.5 Future Perspectives Against MDR-TB; References; 4 Non-antibiotics - An Alternative for Microbial Resistance: Scope and Hope; 4.1 Introduction; 4.2 Historical Development: Non-antibiotics with Antimicrobial Potential 4.3 Psychotherapeutics as Non-antibiotics4.4 Sedatives and Tranquilizers as Non-antibiotics; 4.5 Antihistaminics as Non-antibiotics; 4.6 In vitro and In vivo Antimicrobial Potential of Non-antibiotics; 4.6.1 Antiviral Activity of Non-antibiotics; 4.6.2 Antibacterial Activity of Non-antibiotics; 4.6.3 Activity Against Diarrheagenic Bacteria; 4.6.4 Activity Against Mycobacteria; 4.6.5 Activity Against Protozoa; 4.7 Single and Combined Activity Against Bacteria; 4.8 Synergism and .Reversal of Resistance.: A Special Synergy; 4.8.1 Clinical Synergism; 4.8.2 Reversal of Resistance 4.9 Mechanism of Action of Non-antibiotics |
| Record Nr. | UNINA-9910144401203321 |
| Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New strategies combating bacterial infection / / edited by Iqbal Ahmad and Farrukh Aqil
| New strategies combating bacterial infection / / edited by Iqbal Ahmad and Farrukh Aqil |
| Pubbl/distr/stampa | Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2009 |
| Descrizione fisica | 1 online resource (324 p.) |
| Disciplina |
362.196/92
616.92 |
| Soggetto topico |
Bacterial diseases - Prevention
Bacterial diseases - Treatment |
| ISBN |
1-282-02638-0
9786612026386 3-527-62293-4 3-527-62294-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
New Strategies Combating Bacterial Infection; Contents; Preface; List of Contributors; 1 Molecular Mechanisms of Antibiotic Resistance: The Need for Novel Antimicrobial Therapies; 1.1 Introduction; 1.2 Molecular Mechanisms of Resistance; 1.3 β-Lactams; 1.4 Glycopeptides; 1.5 Lantibiotics; 1.6 Aminoglycosides; 1.7 Macrolides; 1.8 Tetracyclines; 1.9 Fluoroquinolones; 1.10 Conclusions; References; 2 Novel Approaches to Combat Drug-Resistant Bacteria; 2.1 Introduction; 2.2 Approaches to Antibacterial Drug Discovery and Combating the Problem of Drug Resistance
2.2.1 Search for New Antibiotics from Microbial Sources2.2.1.1 Conventional Culturing Methods; 2.2.1.2 Novel Culturing Environments; 2.2.1.3 Heterologous DNA-Based Approaches; 2.2.1.4 Metagenomics and Molecular Engineering; 2.2.2 Role of Genomics in New Antibacterial Drug Discovery; 2.2.3 Antimicrobial Peptides as New Anti-Infective Drugs; 2.3 Combination Drug Therapy; 2.4 Strategies to Target Mechanisms of Drug Resistance; 2.4.1 Bacterial Efflux Systems and Efflux Pump Inhibition; 2.5 Quorum Sensing Inhibition: A Novel Anti-Infective Drug Target; 2.5.1 Anti-QS Compound Effects In Vitro 2.5.2 Efficacy of QS-Inhibitory Compounds in Animal Infection Models2.6 Phage Therapy: An Alternative Therapy; 2.7 Antibiotic Use Policy: Practical Management of the Problem of Antibiotic Resistance; 2.8 Conclusions; References; 3 Promising Current Drug Candidates in Clinical Trials and Natural Products Against Multidrug-Resistant Tuberculosis; 3.1 Introduction; 3.2 Current MDR-TB Treatment; 3.3 Current Drugs in Development Against MDR-TB; 3.3.1 Fluoroquinolones (Gatifloxacin and Moxifloxacin); 3.3.1.1 Fluoroquinolones against MDR-TB; 3.3.1.2 Gatifloxacin; 3.3.1.3 Moxifloxacin; 3.3.2 PA-824 3.3.3 Diarylquinoline TMC2073.3.4 Nitroimidazo-Oxazole OPC-67683; 3.3.5 SQ-109; 3.3.6 Pyrrole LL-3858; 3.4 Natural Products Against MDR-TB; 3.4.1 Fungi; 3.4.1.1 Thiolactomycin; 3.4.1.2 Pacidamycin Family; 3.4.1.3 Capuramycin; 3.4.1.4 Caprazamycin; 3.4.2 Plants; 3.4.2.1 Calanolide; 3.4.2.2 Diospyrin; 3.4.3 Marine Natural Products; 3.4.3.1 Aerothionin; 3.5 Future Perspectives Against MDR-TB; References; 4 Non-antibiotics - An Alternative for Microbial Resistance: Scope and Hope; 4.1 Introduction; 4.2 Historical Development: Non-antibiotics with Antimicrobial Potential 4.3 Psychotherapeutics as Non-antibiotics4.4 Sedatives and Tranquilizers as Non-antibiotics; 4.5 Antihistaminics as Non-antibiotics; 4.6 In vitro and In vivo Antimicrobial Potential of Non-antibiotics; 4.6.1 Antiviral Activity of Non-antibiotics; 4.6.2 Antibacterial Activity of Non-antibiotics; 4.6.3 Activity Against Diarrheagenic Bacteria; 4.6.4 Activity Against Mycobacteria; 4.6.5 Activity Against Protozoa; 4.7 Single and Combined Activity Against Bacteria; 4.8 Synergism and .Reversal of Resistance.: A Special Synergy; 4.8.1 Clinical Synergism; 4.8.2 Reversal of Resistance 4.9 Mechanism of Action of Non-antibiotics |
| Record Nr. | UNINA-9910830082403321 |
| Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
